By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



Lejrvej 37-41

Værløse    DK-3500  Denmark
Phone: 45-44-47-80-80 Fax: 45-44-47-24-25



Company News
Egalet Hires Paul Varki As Senior Vice President And General Counsel 11/16/2015 9:00:46 AM
Egalet Announces Issuance Of U.S. Patent Covering Guardian Technology And Its Abuse-Deterrent Product Candidates 11/12/2015 7:36:37 AM
Egalet Reports Third Quarter 2015 Financial Results And Provides Business Update 11/4/2015 9:46:39 AM
Egalet To Participate In Abuse-Deterrent Formulation And Investor Conferences And Will Co-Host A Category 1 Focus Group Meeting In November 10/28/2015 11:34:33 AM
Egalet To Host Conference Call And Webcast To Discuss Third Quarter 2015 Financial Results On November 4, 2015 10/21/2015 11:54:45 AM
Egalet Appoints Mark Strobeck, Ph.D. To Executive Vice President And Chief Operating Officer 10/5/2015 6:26:25 AM
Egalet Provides Commercial Update On SPRIX Nasal Spray And OXAYDO Along With Pipeline Review At Investor Day 9/29/2015 6:40:35 AM
Egalet Announces Investor Day 9/15/2015 8:46:24 AM
Egalet Announces Scientific Data At PAINWeek 2015 Meeting Supports Analgesic Efficacy Of SPRIX Nasal Spray Versus Commonly Prescribed Oral Combination Opioids In Treatment Of Moderate To Severe Short-Term Pain 9/10/2015 6:46:17 AM
Egalet Announces Commercial Launch Of OXAYDO, The First And Only Immediate-Release Oxycodone Designed To Discourage Intranasal Abuse, And Launch Of IMPACT-Rx, A Patient Access Initiative 9/9/2015 6:07:54 AM